You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

  1. CORPORATE - 26-05-2016

    SIPPET study results published in the “New England Journal of Medicine”

    This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world

    read more 

  2. CORPORATE - 06-05-2016

    Kedrion Biopharma for Mother's Day

    We are committed to helping eliminate Rh disease worldwide by supporting initiatives like CURhE

    read more 

  3. CORPORATE - 07-03-2016

    CURhE, Global Alliance for mother and child healthcare

    Kedrion among the founding members. The aim is Rh disease eradication

    read more 

  4. CORPORATE - 19-01-2016

    Kedrion Biopharma strengthens its position on the US market

    Granted exclusive rights to commercialize a lifesaving drug in the US

    read more 

Pages

For more information please contact: pressoffice@kedrion.com